[ad_1]
In an interview broadcast on national public television ARD, the chancellor highlighted the publication of “good data” on a Russian vaccine called Sputnik V, and also spoke with Russian President Vladimir Putin about an investigation to be launched at the EMA, the authority of Community pharmacovigilance. .
Representing Member States in the procurement of vaccines and product launches, the European Commission emphasized that the vaccination campaign in the United States, Great Britain, Israel and even Serbia was progressing faster than in the EU, but “practically nothing It had been successful, and it was not wrong to make the vaccine marketing authorization conditional on a full EMA review.
He stressed that the confidence of the population is essential for the success of the vaccination campaign, which requires a meticulous pharmacovigilance study of the vaccines. In meeting with leaders of the federal and provincial governments on Monday with industry professionals It has also been made clear that moving even more money does not allow obtaining even more vaccines because production capacity is limited. Therefore, the United States hardly exports any vaccine, so the vaccine jointly developed between the American Pfizer and the German BioNTech. You cannot trust Pfizer plants in the United States, but only the capacity available in the EU.
This will be expanded as BioNTech’s own plant in Marburg, Germany is built at a very rapid pace and the authorities will provide all assistance for this work.
Angela Merkel explained.
Among other things, he said that in Germany, nearly 10 million people could be vaccinated against SARS-CoV-2 in the first trimester, and even the most conservative estimates suggest that all adults could receive at least the first dose by the end of the trimester. Summer, September 21.
According to the Robert Koch Institute for Public Health (RKI), approximately 2.8 percent of the German population, 2,586,997 people, had been vaccinated against SARS-Cov-2 as of Tuesday, of which 606,786 people had received both doses of the vaccine.
The second wave of the epidemic, which developed last fall, is receding. RKI showed on Tuesday that 6,114 infections were tested nationwide in the last 24 hours. This is a decrease from 6412 from a week earlier. Along with recently reported infections, SARS-CoV-2 has been detected in 2,228,085 people. 861 deaths were reported in relation to the disease caused by the virus (Covid-19), bringing the number of victims of the epidemic to 57,981.
Cover image source: MTI / EPA / Hayoung Jeon
[ad_2]
